Multi-drug resistant tuberculosis in context of RNTCP.
DOTS has been successful in improving cure rates in tuberculosis worldwide, but has remained an inefficient strategy in respect of multidrug-resistant tuberculosis (MDR TB). The present article discusses its management in context of RNTCP and focuses specially on DOTS-plus, a strategy arising out of the constitution of Green Light Committee to effectively tackle the cases of MDR TB globally.
Arora
V K
VK
Department of TB and Chest Diseases, LRS Institute of TB and Respiratory Diseases, Sri Aurobindo Marg, New Delhi, India. vk_raksha@vsnl.in
Visalakshi
P
P
D023801:Directly Observed Therapy / Q000592:standards*; D006801:Humans; D007194:India; D009313:National Health Programs / Q000592:standards*; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000628:therapy*